Location History:
- Itajai, BR (2015)
- Navegantes, BR (2023)
Company Filing History:
2 out of 5,072 
1 out of 78 
Years Active: 2015-2023
Title: Franceline Reynaud: Innovator in Pharmaceutical Formulations
Introduction
Franceline Reynaud is a notable inventor based in Itajai, Brazil. She has made significant contributions to the field of pharmaceutical formulations, particularly in the development of innovative drug delivery systems. With a total of 2 patents, her work focuses on improving the efficacy and safety of medications.
Latest Patents
One of her latest patents is titled "Nanoparticulate prodrugs." This invention relates to an anti-inflammatory drug formulation, specifically a corticosteroid prodrug nanoparticle. The invention encompasses a nanoparticle that includes a therapeutic agent and a surface coating material. Additionally, it outlines a process for manufacturing these nanoparticles, along with pharmaceutical compositions and kits.
Another significant patent is for a "Galenic form suitable for absorbing, in a specific manner, the undesirable molecules in the digestive tract." This invention involves particles that can specifically adsorb undesirable molecules present in the digestive tract. It also details the method for preparing these particles and their use in producing medicines aimed at preventing or treating adverse effects linked to imbalances in intestinal or colonic flora, often resulting from antibiotic treatments.
Career Highlights
Franceline Reynaud has worked with prestigious institutions, including the Centre National De La Recherche Scientifique and Université Paris-Saclay. Her experience in these organizations has contributed to her expertise in pharmaceutical research and development.
Collaborations
Throughout her career, she has collaborated with notable colleagues such as Elias Fattal and Nicolas Tsapis. These partnerships have further enhanced her research and innovation in the field.
Conclusion
Franceline Reynaud is a pioneering inventor whose work in pharmaceutical formulations has the potential to significantly impact drug delivery and efficacy. Her innovative patents reflect her commitment to advancing medical science and improving patient outcomes.